Lung cancer
Conditions
Interventions
research group:Perioperative management of single port thoracoscopic lobectomy using ERAS concept
1 Preoperative education and psychological intervention, ERAS management measures including preoperati
Especially for patients who have many concerns about surgery and prognosis, introduce the relevant matters of surgery to eliminate concerns
Prior to surgery, inform the patient of the surgical method, incision size, and the purpose of postoperative chest tube placement, emphasizing the advantages of single port thoracoscopy surgery.
2 Pr
Fasting 6 hours before surgery, drinking 300-500 ml of water 2 hours before surgery
intravenous infusion of antibiotics 30 minutes before surgery.
3 During the operation, pay attention to keeping the patient warm during routine disinfection, and use anesthetics with a short half-lif
During the operation, a protective sheath is used to protect the incision, and gentle operation is performed to avoid excessive pulling or squeezing of lung tissue
Intraoperative restricted fluid replacement, using vasoactive drugs to raise blood pressure, with a fluid replacement volume of less than 1000 ml. Place a thoracic drainage tube and lead it out from t
Sponsors
Shifang people's Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1) All patients have a clinical pathological stage of stage I; 2) All patients' pathological and imaging examinations meet the diagnostic criteria for non-small cell lung cancer (Chinese Primary Lung Cancer Diagnosis and Treatment Standards 2015 edition); 3) All patients were diagnosed with a single lesion with a diameter of less than or equal to 2.0cm; 4) All patients did not receive chemotherapy before surgery; 5) All patients meet the conditions for single port thoracoscopic lobectomy surgery; 6) All patients have normal consciousness; 7) All patients agreed to participate in this study.
Exclusion criteria
Exclusion criteria: 1) Patients with clinical pathological stage>Stage I; 2) Patients with consciousness disorders; 3) Patients undergoing radiotherapy or chemotherapy; 4) Not meeting the conditions for single port thoracoscopic lobectomy surgery; 5) Individuals with a history of malignant tumors; 6) Refusal to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores;Hypersensitive C-reactive protein;Interleukin-6;white blood cell count;Percentage of neutrophils;length of hospital stay; | — |
Secondary
| Measure | Time frame |
|---|---|
| First time getting out of bed after surgery;Tube time;Total hospitalization expenses;patient satisfaction;The incidence of postoperative complications; | — |
Countries
China
Contacts
Public ContactYuan Bing
Shifang people's Hospital, Shifang, Sichuan Province, China
Outcome results
None listed